Meet LCFA's Amazing Researchers
Meet these leading scientists focused on lung cancer research, new treatments, and enhancing the lives of those living with lung cancer.
-
Kellie Smith, PhD
Leading an immunology lab in transformative cancer research
Immunotherapy in Early Stage Lung Cancer
-
Zoltan Lohinai, MD, PhD
Pulmonary oncologist and researcher
Exploring the biomarker potential of the gut microbiome in patients undergoing immunotherapy for lung cancer
-
Kathryn Beckermann, MD, PhD
Tumor microenvironment related to the response rate to immunotherapy
Increasing the response rate and effectiveness of immunotherapy
-
Alice Berger, PhD
Discovering how changes to genetic code lead to cancer
Genomic Characterization of Lung Cancer in Never-Smokers
-
Christine Lovly, MD, PhD
Physician-scientist with a special interest in thoracic malignancies
Improving therapies for targeted molecular groups in lung cancer
-
Carla Martins, MD
Principal Investigator
Exploiting the metabolic heterogeneity of mutant KRAS lung tumors to optimize therapy.
-
Daniel Costa, MD
Medical Oncology
Define which mutated tumors can reap the known palliative and survival benefits of approved EGFR treatments
-
Jessica Donington, MD, MSCR
Independent investigator in Thoracic Oncology
Investigations into the role of osteopontin in non-small cell lung cancer
-
Goeffrey Liu, MSC, MD
Medical oncology with a specialization in lung cancer
Studying of the genetic differences in patients treated with anti-angiogenic agents
Your generosity fuels tomorrow's breakthroughs
LCFA’s 22 Early Career Researcher grants, totaling $4.4 million, have already generated $43 million in additional research funding. That’s a 10X return on investment in the fight against lung cancer.